Business

Apogee Therapeutics CEO Michael Henderson and CMO Carl Dambkowski Sell Over $780k in Shares

Jul 6, 2024 1 min read

Jump to Summary

Michael Henderson, CEO of Apogee Therapeutics Inc. (NASDAQ:APGE), sold 15,000 shares on July 5, 2024, according to a recent SEC filing. The shares were sold at an average price of $37.26, resulting in a total transaction value of approximately $558,900. Following this sale, Henderson now holds 1,474,487 shares of the company. The transaction was executed under a Rule 10b5-1 trading plan, which allows company insiders to sell a predetermined number of shares at a set time, potentially protecting against allegations of insider trading.

Additionally, Carl Dambkowski, Chief Medical Officer of Apogee Therapeutics, sold 5,995 shares on July 3, 2024. These shares were sold at an average price of $37.60, totaling approximately $225,402. Following this transaction, Dambkowski's ownership now stands at 294,793 shares. This sale was also carried out under a Rule 10b5-1 trading plan adopted on September 27, 2023. Despite these insider sales, Apogee Therapeutics has experienced positive investor interest due to a 79.09% return on assets over the past year, although concerns remain about the company's profitability and financial stability in the near term. The company's market cap is approximately $2.143 billion, and its recent earnings report showed a quarterly loss of ($0.64) per share, missing analysts' estimates.

#business-leaders #finance #markets

Summary

Other news in business

Draghi Calls for €800bn EU Investment to Compete Globally

The European Union (EU) requires a more coordinated industrial policy, rapid decision-making, and significant investment to remain competitive with the United States and China, according to a report by former European Central Bank chief and Italian Prime Minister, Mario Draghi. The report, commissioned by the European Commission, calls for an

Lilly Promotes Lucas Montarce to EVP and CFO

Eli Lilly and Company (Lilly) has appointed Lucas Montarce as its new executive vice president and chief financial officer (CFO), effective immediately. Montarce, who joined Lilly in 2001, has held various finance leadership roles, including group vice president, corporate controller, and global CFO of Lilly Research Laboratories, Lilly International, and

Methanex Acquires OCI's Methanol Business for $2.05 Billion

OCI Global has entered into a binding equity purchase agreement to sell its Global Methanol Business to Methanex Corporation for $2.05 billion. The transaction will be settled through a combination of $1.15 billion in cash, the issuance of 9.9 million shares of Methanex valued at approximately $450

James Gandolfini Dared HBO Exec to Fire Him During 'Sopranos' Intervention

Former HBO CEO Chris Albrecht has disclosed that James Gandolfini once challenged him to "fire" him from "The Sopranos" after an intervention was staged to persuade the actor to enter rehab for his alcohol struggles. The revelation is part of the new documentary, "Wise Guy: